首页> 外文期刊>Trends in pharmacological sciences >Fighting cancers from within: augmenting tumor immunity with cytokine therapy.
【24h】

Fighting cancers from within: augmenting tumor immunity with cytokine therapy.

机译:从内部对抗癌症:通过细胞因子疗法增强肿瘤免疫力。

获取原文
获取原文并翻译 | 示例
       

摘要

The human immune system has successfully evolved to fight many pathogens. Through vaccination, we can harness and improve immune responses to eradicate infections. Despite this success, we are only now beginning to understand the natural tumor immune surveillance mechanisms and why, in some instances, our immune system fails to abrogate the development and growth of tumors. Encouraging results with the latest immunotherapies have renewed enthusiasm in the field. A central component of these therapies is the contribution of cytokines. Here we review our expanding knowledge of cytokine-induced effects as well as preclinical and clinical data that indicate adjuvant cytokine therapies may hold much promise in improving anti-tumor immunity. Further studies on optimal synergistic combinations, timing, duration and additional adjuvant therapies are required to realize the full potential of cytokines as immunotherapeutic agents.
机译:人类的免疫系统已成功进化出与多种病原体作斗争。通过接种疫苗,我们可以利用和改善免疫反应来消除感染。尽管取得了成功,但我们才刚刚开始了解自然的肿瘤免疫监视机制,以及为什么在某些情况下我们的免疫系统无法消除肿瘤的发生和生长。最新的免疫疗法令人鼓舞的结果重新激发了该领域的热情。这些疗法的主要组成部分是细胞因子的贡献。在这里,我们回顾了我们对细胞因子诱导作用的不断扩展的知识以及临床前和临床数据,这些数据表明辅助细胞因子疗法可能在改善抗肿瘤免疫方面具有广阔的前景。为了实现细胞因子作为免疫治疗剂的全部潜力,需要对最佳协同组合,时间,持续时间和其他辅助疗法进行进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号